0001562180-19-000469.txt : 20190124
0001562180-19-000469.hdr.sgml : 20190124
20190124130450
ACCESSION NUMBER: 0001562180-19-000469
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190124
FILED AS OF DATE: 20190124
DATE AS OF CHANGE: 20190124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RICHARDS MARK W
CENTRAL INDEX KEY: 0001250358
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33326
FILM NUMBER: 19539203
MAIL ADDRESS:
STREET 1: C/O PEOPLE'S UNITED BANK
STREET 2: 850 MAIN STREET
CITY: BRIDGEPORT
STATE: CT
ZIP: 06604
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: People's United Financial, Inc.
CENTRAL INDEX KEY: 0001378946
STANDARD INDUSTRIAL CLASSIFICATION: SAVINGS INSTITUTION, FEDERALLY CHARTERED [6035]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O PEOPLE'S BANK
STREET 2: 850 MAIN STREET
CITY: BRIDGEPORT
STATE: CT
ZIP: 06604
BUSINESS PHONE: 203-338-4114
MAIL ADDRESS:
STREET 1: C/O PEOPLE'S BANK
STREET 2: 850 MAIN STREET
CITY: BRIDGEPORT
STATE: CT
ZIP: 06604
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-01-24
false
0001378946
People's United Financial, Inc.
PBCT
0001250358
RICHARDS MARK W
353 PARK LAUGHTON ROAD
EAST DUMMERSTON
VT
05346
true
false
false
false
Common Stock
2019-01-24
4
S
false
6800.00
16.4333
D
299834.00
D
Series A Nonconvertible Perpetual Preferred Stock
8000.00
D
Common Stock
4768.00
I
By daughter
Includes 108,588 investment units accrued under the Chittenden Corporation Deferred Compensation Plan (including 1,361 units accrued due to the deemed reinvestment of dividend equivalents). Each investment unit corresponds to one share of common stock.
/s/ Kristy Berner, attorney-in-fact
2019-01-24
EX-24
2
michaelcloonanpoa2019.txt
MARK RICHARDS OCT 2018 POA
POWER OF ATTORNEY
I, the undersigned, hereby authorize and designate Anne Marie
Cook (SVP, General Counsel), Kimi Iguchi (Chief Financial Officer),
Erin Lanciani (SVP, People and Organizational Strategy), and Jennifer
Fitzpatrick (Vice President, Corporate Counsel) for as long as they
remain employees of Sage Therapeutics, Inc., and Laurie Burlingame of
Goodwin Procter, each acting singly, or their successors in role, to
take the following actions, acting as my agent and attorney-in-fact,
with full power of substitution:
(1) to prepare and sign on my behalf any Form 3, Form 4 or
Form 5 pursuant to Section 16 of the Securities Exchange Act of 1934,
as amended, and to file the same with the Securities and Exchange
Commission, NASDAQ, NYSE, and each stock exchange on which shares of
Common Stock or other securities of Sage Therapeutics, Inc. are
listed, as required by law;
(2) to prepare and sign on my behalf any Form 144
pursuant to the Securities Act of 1933, as amended, and to file the
same with the Securities and Exchange Commission, NASDAQ, NYSE, and
each stock exchange on which shares of Common Stock or other
securities of Sage Therapeutics, Inc. are listed, as required by law;
and
(3) take any other action necessary or proper in
connection with the foregoing.
Unless earlier revoked under the next sentence, this Power of
Attorney shall remain in effect as long as I am an executive officer
or director of Sage Therapeutics, Inc., and shall not be affected by
my subsequent disability or incompetence. I may revoke this Power of
Attorney by written notice delivered, in person or by nationally
recognized courier, to the attention of the SVP, General Counsel of
Sage Therapeutics, Inc.
/s/ Michael Cloonan
___________________________________________________
(Signature of Executive Officer or Director)
Name: Michael Cloonan
Date: 1/02/2019